MedPath

A study to compare efficacy of AGNIMANTH MOOL CHOORNA AND HARIDRAKHANDA CHOORNA in management of SHEETPITTA.(URTICARIA)

Phase 3
Not yet recruiting
Conditions
Diseases of the skin and subcutaneous tissue,
Registration Number
CTRI/2022/06/043083
Lead Sponsor
CARC Nigdi Pune
Brief Summary

This study is randomized  clinical study parallel group comparing efficacy of Agnimanth mool choorna 3 gms twice a day and  Haridrakhanda Choorna  1 gm twice a day for 1 month in 60 patients with Shitpitta(urticaria)..

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients between ages 20-60 yrs irrespective of gender,religion & occupation.
  • Patients having Granthokt lakshanas of sheetpitta.
Exclusion Criteria
  • Patients having any associated major illness like 1) Renal failure.
    1. Diabetes mellitus.
    1. Systemic Lupus Erythematous.
    1. Rheumatic disorders.
    1. Any type of malignant diseases e.g. Leukaemia metastatic cancer etc.
  • Patient taking treatment from any other pathy for the same problem.
  • Hypersensitivity reactions to any drug.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of AGNIMANTH MOOL CHOORNA AND HARIDRAKHANDA CHOORNA in the management of Sheetpitta(Urticaria).30 Days on follow up on 7 days.
Secondary Outcome Measures
NameTimeMethod
To Study The Side Effects of Drug If Any.30 Days

Trial Locations

Locations (1)

Ayurveda Rungalay And Sterling Multispeciality Hospital Nigdi

🇮🇳

Pune, MAHARASHTRA, India

Ayurveda Rungalay And Sterling Multispeciality Hospital Nigdi
🇮🇳Pune, MAHARASHTRA, India
DR YOGENDRA MORE
Principal investigator
8830579647
dryogendramore@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.